Hydrogen sulphide alleviates platelet dysfunction in patients with type 2 diabetes

Area of Science:

• Biochemistry
• Cardiovascular Science
• Metabolic Disorders

Background:

• Hyperglycaemia is a hallmark of diabetes and is associated with increased cardiovascular risk.
• Platelet activation plays a critical role in the development of thrombotic events.
• Hydrogen sulfide (H2S) is an endogenous gasotransmitter with known protective effects in the cardiovascular system.

Purpose of the Study:

• To investigate the effect of hyperglycaemia on platelet activation.
• To determine the role of hydrogen sulfide (H2S) in mediating platelet responses under hyperglycaemic conditions.
• To evaluate the potential of exogenous H2S supplementation in preventing hyperglycaemia-induced platelet activation.

Main Methods:

• Platelet aggregation assays were performed under normal and hyperglycaemic conditions.
• Platelet hydrogen sulfide (H2S) concentrations were measured.
• The effects of exogenous H2S supplementation on platelet activation were assessed in a hyperglycaemic environment.

Main Results:

• Hyperglycaemia was found to significantly reduce platelet hydrogen sulfide (H2S) concentrations.
• This reduction in H2S was associated with enhanced platelet activation.
• Exogenous supplementation with H2S effectively reversed the abnormal platelet activation observed under hyperglycaemic conditions.

Conclusions:

• Decreased endogenous hydrogen sulfide (H2S) contributes to platelet hyperactivation in hyperglycaemia.
• Hydrogen sulfide (H2S) supplementation represents a potential therapeutic strategy to mitigate cardiovascular events associated with hyperglycaemia.